The New Pharmacotherapy of Schizophrenia

This book consists of 10 chapters authored by 19 leading researcher/ clinicians (18 M.D.s and 1 Ph.D.). All contributors are in the United States and from four states—Maryland, California, Connecticut, and New York. Dr. Breier, the Editor for this volume, is Chief of The Unit on Pathophysiology and Treatment, Experimental Therapeutics Branch, NIMH, in Bethesda, Maryland.